Abstract
The family Zygophyllaceae has almost 22 genera and more than 250 species. Fagonia is an important genus of the family Zygophyllaceae. This genus comprises abundant species, which grows in different phytogeographical regions of the world. These species grow in different environmental conditions. Fagonia indica belongs to Zygophyllaceae. It is commonly known as Dhamasa, Dhamana, Sachi booti and Shoka’a and is found in deserts of Asia and Africa. The species of this family are of very high importance. This article is a review based on different studies regarding occurrence, phytochemistry, traditional uses, biochemical constituents and therapeutic uses of F. indica. The available literature review provided a base for this review. The presence of flavonoids, saponins, tannins, glycosides, pectin and alkaloids was confirmed by different researchers. F. indica is a very important medicinal plant because it has different therapeutic and traditional uses such as antidiabetic, anticancer, anti leishmanial, antipyretic, anti-inflammatory, laxative, gastroprotective, hepatoprotective and antioxidant effects. Further in vitro and in vivo studies should be carried out to find the exact mechanisms of actions for better scientific evidence.
Keywords: Fagonia indica, phytochemistry, traditional uses, pharmacological profile, therapeutic potential, future prospects, Nutritious value.
Current Pharmaceutical Design
Title:Fagonia indica; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities
Volume: 27 Issue: 22
Author(s): Kashif Ali and Haroon Khan*
Affiliation:
- Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan 23200,Pakistan
Keywords: Fagonia indica, phytochemistry, traditional uses, pharmacological profile, therapeutic potential, future prospects, Nutritious value.
Abstract: The family Zygophyllaceae has almost 22 genera and more than 250 species. Fagonia is an important genus of the family Zygophyllaceae. This genus comprises abundant species, which grows in different phytogeographical regions of the world. These species grow in different environmental conditions. Fagonia indica belongs to Zygophyllaceae. It is commonly known as Dhamasa, Dhamana, Sachi booti and Shoka’a and is found in deserts of Asia and Africa. The species of this family are of very high importance. This article is a review based on different studies regarding occurrence, phytochemistry, traditional uses, biochemical constituents and therapeutic uses of F. indica. The available literature review provided a base for this review. The presence of flavonoids, saponins, tannins, glycosides, pectin and alkaloids was confirmed by different researchers. F. indica is a very important medicinal plant because it has different therapeutic and traditional uses such as antidiabetic, anticancer, anti leishmanial, antipyretic, anti-inflammatory, laxative, gastroprotective, hepatoprotective and antioxidant effects. Further in vitro and in vivo studies should be carried out to find the exact mechanisms of actions for better scientific evidence.
Export Options
About this article
Cite this article as:
Ali Kashif and Khan Haroon *, Fagonia indica; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities, Current Pharmaceutical Design 2021; 27 (22) . https://dx.doi.org/10.2174/1381612826666201210105941
DOI https://dx.doi.org/10.2174/1381612826666201210105941 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Pilot Study for Investigation of Plasma Amino Acid Profile in Neurofibromatosis Type 1 Patients
Combinatorial Chemistry & High Throughput Screening In vitro and in vivo Evaluation of Antitumor Drug-Loaded Aptamer Targeted Single-Walled Carbon Nanotubes System
Current Pharmaceutical Biotechnology Magnetic and Gold-Coated Magnetic Iron Oxide Nanoparticles as Detection Tools: Preparation, Characterization, and Biosensing Applications
Current Nanoscience Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes
Current Medicinal Chemistry Dual-modality Chemo-photodynamic Therapy Using RB and DOX as Anti-cancer Drugs by PAMAM-grafted Hollow Porous Silica Nanoparticles
Current Nanoscience Modulators of Inhibitor of Growth (ING) Family Expression in Development and Disease
Current Drug Targets Synthesis, Anticancer Screening and Molecular Docking Studies of New Heterocycles with Trimethoxyphenyl Scaffold as Combretastatin Analogues
Mini-Reviews in Medicinal Chemistry Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids
Current Drug Metabolism Potential Use of Food Protein-Derived Peptides in the Treatment of Inflammatory Diseases
Protein & Peptide Letters Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity
Anti-Cancer Agents in Medicinal Chemistry Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Status of Bi- and Multi-Nuclear Platinum Anticancer Drug Development
Anti-Cancer Agents in Medicinal Chemistry Pancreatic Cancer Metastasis: Are we being Pre-EMTed?
Current Pharmaceutical Design Quinone Methides as DNA Alkylating Agents: An Overview on Efficient Activation Protocols for Enhanced Target Selectivity
Current Organic Chemistry NAD<sup>+</sup>/NADH Metabolism and NAD<sup>+</sup>-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications
Current Medicinal Chemistry Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?
Current Pharmaceutical Design Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations
Current Medicinal Chemistry Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
Current Medicinal Chemistry Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine Design, Synthesis and Antitumor Activity of Quinazoline Derivatives Bearing 2,3-Dihydro-indole or 1,2,3,4-Tetrahydroquinoline
Letters in Drug Design & Discovery